SuperGen to Present at Thomas Weisel Partners Healthcare Conference September 5th

DUBLIN, Calif., Aug. 29 SuperGen Inc.(Nasdaq: SUPG), a pharmaceutical company dedicated to the discovery, rapiddevelopment and commercialization of therapies for solid tumors andhematological malignancies, today announced that James S. Manuso, Ph.D.,President and Chief Executive Officer is scheduled to present at the ThomasWeisel Partners Healthcare Conference on September 5, 2007, at the FourSeasons Hotel in Boston.

SuperGen's presentation at the Thomas Weisel Partners HealthcareConference is scheduled to begin at 2:40 p.m. EDT. A live webcast of thepresentation will be available on the investor relations section of theCompany's Web site at www.supergen.com. The webcast will be archived for 90days.

About SuperGen

Based in Dublin, Calif., SuperGen, Inc. is a pharmaceutical companydedicated to the discovery, rapid development and commercialization oftherapies for solid tumors and hematological malignancies. SuperGen isdeveloping a number of therapeutic anticancer products focused on kinase andcell signaling inhibitors and DNA methyltransferase inhibitors. For moreinformation about SuperGen, please visit http://www.supergen.com.Contacts Timothy L. Enns SuperGen, Inc. SVP, Corporate Communications & Business Development Tel: (925) 560-0100 E-mail: [email protected] Mary M. Vegh SuperGen, Inc. Manager, Investor Relations Tel: (925) 560-2845 E-mail: [email protected]

SOURCE SuperGen Inc.

Latest Press Release on General News

Ministerial Statement on the International Day Against Homophobia, Transphobia, and Biphobia

GATINEAU , QC , May 17, 2024 /CNW/ - The Honourable Marci Ien, Minister for Women and Gender Equality and Youth, the Honourable Mark Holland, Minister of Health, and the Honourable...

The Oxford-Harrington Rare Disease Centre Announces Newly Funded Grant Award Programmes to Develop New Therapies for Friedreich's Ataxia

OXFORD, United Kingdom and CLEVELAND , May 17, 2024 /PRNewswire/ -- The Oxford-Harrington Rare Disease Centre ('OHC'), a partnership (between the University of Oxford , UK and ...

Limaca Medical Completes 24 EUS Pancreatic and Liver Biopsy Cases

Limaca's Precision-GI™ endoscopic ultrasound guided motorized fine needle biopsy (EUS-mFNB) device delivers substantial tissue acquisition. YOKNEAM, Israel , May 15, 2024 /PRNew...

Accumulus Synergy Sponsors Revolutionary Healthcare Data Standard, Advancing Towards Global Dossier

BURLINGAME, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- Accumulus Synergy, Inc. (“Accumulus”), a nonprofit industry association enhancing data exchange for the life sciences-regulatory i...

Single-Cell Multi-Omics Analysis of IASO Bio's Equecabtagene Autoleucel in the Treatment of Autoimmune Diseases of the Central Nervous System Published in Science Immunology

SHANGHAI , NANJING , China , and SAN JOSE, Calif. , May 10, 2024 /PRNewswire/ -- On May 10, 2024 , the impactful international academic journal, Science Immunology , a sub-j...